Innovation1 Biotech Inc. (IVBT)

USD 0.0

(-95.45%)

Total Assets Summary of Innovation1 Biotech Inc.

Innovation1 Biotech Inc.'s latest annual total assets in 2023 was 75.99 Thousand USD , down -99.83% from previous year.
Innovation1 Biotech Inc.'s latest quarterly total assets in 2023 FY was 75.99 Thousand USD , down -99.83% from previous quarter.
Innovation1 Biotech Inc. reported annual total assets of 43.96 Million USD in 2022, up 24070.86% from previous year.
Innovation1 Biotech Inc. reported annual total assets of 181.88 Thousand USD in 2021, down -12.81% from previous year.
Innovation1 Biotech Inc. reported quarterly total assets of 75.99 Thousand USD for 2023 FY, down -99.83% from previous quarter.
Innovation1 Biotech Inc. reported quarterly total assets of 75.99 Thousand USD for 2023 Q4, down -98.03% from previous quarter.

Annual Total Assets Chart of Innovation1 Biotech Inc. (2023 - 2015)

Historical Annual Total Assets of Innovation1 Biotech Inc. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	75.99 Thousand USD	-99.83%
2022	43.96 Million USD	24070.86%
2021	181.88 Thousand USD	-12.81%
2020	208.6 Thousand USD	-18.65%
2019	256.41 Thousand USD	-70.28%
2018	862.74 Thousand USD	12677.59%
2017	6752.00 USD	32.18%
2016	5108.00 USD	770.19%
2015	587.00 USD	0.0%

Year	Total Assets	Total Assets Growth
2023 Q1	3.83 Million USD	-9.64%
2023 FY	75.99 Thousand USD	-99.83%
2023 Q4	75.99 Thousand USD	-98.03%
2023 Q3	3.85 Million USD	0.0%
2023 Q2	3.85 Million USD	0.54%
2022 Q3	81.16 Million USD	-1.93%
2022 Q1	84.37 Million USD	46290.96%
2022 FY	43.96 Million USD	24070.86%
2022 Q2	82.76 Million USD	-1.91%
2022 Q4	4.24 Million USD	-94.77%
2021 Q2	138.65 Thousand USD	-27.12%
2021 Q4	181.88 Thousand USD	187.91%
2021 FY	181.88 Thousand USD	-12.81%
2021 Q3	63.17 Thousand USD	-54.44%
2021 Q1	190.24 Thousand USD	-8.8%
2020 Q1	369.82 Thousand USD	44.23%
2020 FY	208.6 Thousand USD	-18.65%
2020 Q4	208.6 Thousand USD	-67.94%
2020 Q3	650.72 Thousand USD	2.89%
2020 Q2	632.47 Thousand USD	71.02%
2019 Q1	603 Thousand USD	-30.11%
2019 FY	256.41 Thousand USD	-70.28%
2019 Q4	256.41 Thousand USD	-22.64%
2019 Q3	331.47 Thousand USD	-29.45%
2019 Q2	469.83 Thousand USD	-22.08%
2018 Q4	862.74 Thousand USD	1112.74%
2018 FY	862.74 Thousand USD	12677.59%
2018 Q3	71.14 Thousand USD	3.83%
2018 Q1	62.99 Thousand USD	832.95%
2018 Q2	68.51 Thousand USD	8.77%
2017 FY	6752.00 USD	32.18%
2017 Q1	473.00 USD	-90.74%
2017 Q3	2901.00 USD	1418.85%
2017 Q2	191.00 USD	-59.62%
2017 Q4	6752.00 USD	132.75%
2016 Q1	3856.00 USD	556.9%
2016 Q4	5108.00 USD	0.02%
2016 Q3	5107.00 USD	373.31%
2016 Q2	1079.00 USD	-72.02%
2016 FY	5108.00 USD	770.19%
2015 FY	587.00 USD	0.0%
2015 Q4	587.00 USD	0.0%

Peer Total Assets Comparison of Innovation1 Biotech Inc.

Name	Total Assets	Total Assets Difference
America Great Health	299.12 Thousand USD	74.595%
Gene Biotherapeutics, Inc.	- USD	-Infinity%
Evolutionary Genomics, Inc.	2.35 Million USD	96.771%
Point of Care Nano-Technology, Inc.	124.64 Thousand USD	39.031%
Vicapsys Life Sciences, Inc.	39.65 Thousand USD	-91.631%